Related Experiment Video
Updated: Jul 9, 2025

Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
Benign Mesenteric Lesion Presenting with Features of a Malignant Mass
Josefina Principe1, Anna Mary Jose2, Santiago Niño Basto3
1Department of Surgery, Pontifical Catholic University of Argentina, Buenos Aires, Argentina.
Abstract:
Encapsulated fat necrosis (EFN), most commonly, is an asymptomatic entity and is often found incidentally in images. However, in the abdomen, it may present as an acute abdomen. Mesenteric fat necrosis is part of a larger disease spectrum called collectively mesenteric sclerosis. It results in forming of a mass that can be confused with other pathologies such as liposarcoma, carcinoma of the cecum, and other more benign conditions such as appendagitis of the epiplon. We present the case of an 82-year-old male who presented with an asymptomatic right lower quadrant mass with concerning computed tomography findings with no previous abdominal surgery or trauma history. Diagnosing EFN is crucial as it can mimic bowel cancer and immune-related mesenteric pathology such as sclerosing mesenteritis, the management of which is far more extreme and aggressive than EFN.
Insights
Encapsulated fat necrosis (EFN) can present as an asymptomatic abdominal mass, mimicking serious conditions like cancer. Accurate diagnosis is key to avoid unnecessary aggressive treatments.
Area of Science:
- Gastroenterology
- Radiology
- Pathology
Background:
- Encapsulated fat necrosis (EFN) is often asymptomatic but can manifest as acute abdominal pain.
- Mesenteric fat necrosis falls under the spectrum of mesenteric sclerosis.
- EFN masses can be misdiagnosed as liposarcoma, cecal carcinoma, or epiploic appendagitis.
Observation:
- An 82-year-old male presented with an asymptomatic right lower quadrant mass.
- Computed tomography revealed concerning findings.
- The patient had no prior abdominal surgery or trauma.
Findings:
- The case highlights the diagnostic challenge of EFN.
- EFN can mimic serious intra-abdominal pathologies.
- Distinguishing EFN from malignancy and sclerosing mesenteritis is critical.
Implications:
- Accurate diagnosis of EFN prevents misdiagnosis and inappropriate aggressive management.
- Understanding EFN's mimicry is vital for surgical and oncological decision-making.
- This case underscores the importance of considering benign conditions in abdominal mass evaluation.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
03:37Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors
Published on: December 20, 2024
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Appendicitis-I: Introduction
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...